Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin

Author:

Venturino Antonella,Comandini Danila,Simoni Carlotta,Merlini Laura,Naso Cinzia,Palumbo Raffaella,Fusco Vittorio,Porcile Gianfranco,Pronzato Paolo,Rosso Riccardo,Repetto Lazzarono

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference37 articles.

1. Canellos GP, De Vita VT and Gold GL: Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med 84: 389–392, 1976

2. Sledge GW Jr, Antman KH: Progress in chemotherapy for metastatic breast cancer. Sem Oncol 19: 317–322, 1992

3. Campora E, Gardin G, Gasco M, Conte PF and Rosso R: Does palliative therapy for metastatic breast cancer really palliate? Proc ASCO 15: 96, 1996

4. Porkka K, Blomqvist C, Rissanen P, Elomao I, Pyrhonen S: Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer. J Clin Oncol 12: 1639–1647, 1994

5. Sedlacek SM: Salvage therapy for metastatic disease. Semin Oncol 17 (4) Suppl 7: 45–49, 1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3